Our Co-Founder and CEO, Dr. Chern-Hooi Lim sheds light on the uptake of New Iridium’s photocatalysis technology into the pharmaceutical industry. Read Article Related PostsNew Iridium participates in CSU-led NSF CCI center advancing photocatalysisAugust 18, 2023Dr. Lim pitched at the DOE EPIC Prize event in New OrleansJuly 18, 2023New Iridium CO2-to-chemicals platform featured in Chemical Engineering magazineJuly 1, 2023New Iridium featured in The 2023 Nature Spinoff PrizeMay 24, 2023New Iridium awarded $1M NSF SBIR Phase II grantApril 24, 2023Braskem and New Iridium partner to develop CO2 conversion technologyApril 17, 2023
